MAG
CSBR icon

Millrace Asset Group’s Champions Oncology CSBR Stock Holding History

Millrace Asset Group’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-194,010
Closed -$875K – 56
2022
Q4 		$875K Sell
194,010
-152,966
-44% -$999K 0.99% 40
2022
Q3 		$2.6M Sell
346,976
-7,065
-2% -$59.1K 3.29% 8
2022
Q2 		$2.83M Buy
354,041
+25,061
+8% +$192K 2.65% 8
2022
Q1 		$2.67M Buy
328,980
+2,844
+0.9% +$22.8K 1.94% 17
2021
Q4 		$2.73M Buy
326,136
+2,061
+0.6% +$19K 1.59% 21
2021
Q3 		$3.31M Buy
324,075
+43,636
+16% +$444K 2.07% 9
2021
Q2 		$2.88M Buy
280,439
+20,357
+8% +$206K 1.5% 24
2021
Q1 		$2.94M Buy
260,082
+77,745
+43% +$902K 1.58% 21
2020
Q4 		$1.97M Buy
182,337
+62,228
+52% +$642K 1.37% 33
2020
Q3 		$1.11M Buy
120,109
+65,752
+121% +$585K 0.9% 57
2020
Q2 		$520K Sell
54,357
-28,138
-34% -$240K 0.53% 66
2020
Q1 		$610K Sell
82,495
-17,052
-17% -$119K 0.92% 52
2019
Q4 		$829K Buy
+99,547
New +$615K 0.9% 55

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Millrace Asset Group's CSBR Position: Q1 2023 in Review

Millrace Asset Group sold out of Champions Oncology (CSBR) in Q1 2023, closing a stake of 194,010 shares — an estimated $875K sold.

Millrace Asset Group first reported a position in CSBR in Q4 2019 and held it in 13 quarters. The position peaked at $3.31M in Q3 2021. 30 funds tracked by Wall St. Rank hold CSBR as of Q1 2023.

  • Millrace Asset Group reported no remaining Champions Oncology position as of Q1 2023 after selling out during the quarter.
  • Millrace Asset Group sold 194,010 Champions Oncology shares in Q1 2023, an estimated $875K.
  • Millrace Asset Group first reported a position in Champions Oncology in Q4 2019 and held it in 13 quarters.
  • Millrace Asset Group's Champions Oncology position peaked at $3.31M in Q3 2021.
  • 30 funds tracked by Wall St. Rank held Champions Oncology as of Q1 2023.

Based on Millrace Asset Group's 13F filing for Q1 2023, filed 11 May 2023.